Cerezyme Injection, Powder, Lyophilized, For Solution
Product Images NDC 58468-4663

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cerezyme (NDC 58468-4663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (200 Unit Vial Carton)

This is a medication called Cerezyme, which contains imiglucerase and is used for intravenous infusion after dilution. Each single dose vial contains 424 units of imiglucerase along with mannitol, polysorbate 80, and sodium citrates. The medication must be refrigerated at 2°C to 8°C and should be reconstituted with 10.2 mL of Sterile Water for Injection, USP. The recommended dosage should be consulted from full prescribing information. The storage of the reconstituted and diluted solutions must also be observed. This medication is manufactured by Genzyme Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.